AWAnnalise Weckesser

Annalise Weckesser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annalise Weckesser has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    What We Live and Breathe: Expert Insights on Inclusivity in U.K. Period Poverty Initiatives

    by Emma Craddock, Gemma Williams, Annalise Weckesser

    In the United Kingdom, at least 10% of girls are affected by period poverty (Plan International UK, 2018), broadly defined as limited access to menstrual products, education, and healthcare due to ...

  • Open Access

    Missing Out: A Qualitative Study Exploring Adolescents’ and Young Women’s Experiences of Endometriosis

    by A. E. Randhawa, A. D. Tufte-Hewett, G. L. Jones, A. M. Weckesser

    Endometriosis is a chronic systemic disease (Taylor et al., 2021), in which endometrial-like tissue found outside of the uterine cavity (most commonly on the reproductive organs, bowel, and bladder...

  • Same shit, different crisis? Feminist activism against period poverty during the Covid-19 pandemic in the UK

    by Emma Craddock, Gemma Williams, Annalise Weckesser

    Moments of crisis, such as the Covid-19 pandemic, the 2007 financial crisis, and the ongoing cost-of-living crisis in the United Kingdom, create unique opportunities and challenges for feminist activism. Despite increased awareness, little is known about how organisations engaged in menstrual activism responded to the increased demands of tackling ‘period poverty’ during the pandemic. This article addresses this gap through interviews and survey responses with representatives from such organisations. Findings reveal that period-poverty initiatives (1) constitute a continuation of feminist anti-austerity activism, (2) highlight the triple jeopardy faced by women, and (3) create possibilities for feminist activism that address gendered inequalities. By applying an intersectional feminist ethic-of-care lens, this article provides original insights into the challenges and opportunities organisations faced during the Covid-19 pandemic. The research underscores the necessity for policy interventions that integrate feminist principles to support period-poverty initiatives, ensuring sustainable and equitable solutions. This article contributes to the burgeoning literature on period poverty in the UK, offering implications for feminist activism, organisational practice, and policy development to mitigate gendered economic and social disparities.


  • Open Access

    Associations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis

    by Oladipupo Olalere, Saba Tariq, Olanike Ajijola, Min-Dee Koh, Katie Crabb, Amie Wilson, Anwesa Chatterjee, Mairead Black, Katie Morris, Matthew Bluett-Duncan, et al.

    Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.


  • Open Access

    Experiences of pregnancy and reproductive health for women living with epilepsy: A systematic review

    by Weckesser Annalise, Hughes Anita, Dyson Judith, Raju Sereena, Chatterjee Anwesa, Nelson-Piercy Catherine, Black Mairead, Moss Ngawai, Craig John, Olalere Oladipupo, et al.


  • Open Access

    Seizure prediction in pregnant women with epilepsy: An umbrella review of clinical practice guidelines and systematic reviews

    by Fatima Junaid, Bethan Davies, Saba Tariq, Javier Zamora, Ngawai Moss, Mairead Black, Amie Wilson, Judith Dyson, Annalise Weckesser, John Craig, et al.


  • Open Access

    Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCT

    by Kevin G Cooper, Siladitya Bhattacharya, Jane P Daniels, Versha Cheed, Laura Gennard, Lisa Leighton, Danielle Pirie, Melyda Melyda, Mark Monahan, Annalise Weckesser, et al.

    Background: Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there is uncertainty about the best option. Objectives: To evaluate the clinical and cost-effectiveness of long-acting progestogen therapy compared with the combined oral contraceptive pill in preventing recurrence of endometriosis-related pain and quality of life. Design: A multicentre, open, randomised trial with parallel economic evaluation. The final design was informed by a pilot study, qualitative exploration of women’s lived experience of endometriosis and a pretrial economic model. Setting: Thirty-four United Kingdom hospitals. Participants: Women of reproductive age undergoing conservative surgery for endometriosis. Interventions: Long-acting progestogen reversible contraceptive (either 150 mg depot medroxyprogesterone acetate or 52 mg levonorgestrel-releasing intrauterine system) or combined oral contraceptive pill (30 µg ethinylestradiol, 150 µg levonorgestrel). Main outcome measures: The primary outcome was the pain domain of the Endometriosis Health Profile-30 questionnaire at 36 months post randomisation. The economic evaluation estimated the cost per quality-adjusted life-years gained. Results: Four hundred and five women were randomised to receive either long-acting reversible contraceptive (N = 205) or combined oral contraceptive pill (N = 200). Pain scores improved in both groups (24 and 23 points on average) compared with preoperative values but there was no difference between the two (adjusted mean difference: −0.8, 95% confidence interval −5.7 to 4.2; p = 0.76). The long-acting reversible contraceptive group underwent fewer surgical procedures or second-line treatments compared with the combined oral contraceptive group (73 vs. 97; hazard ratio 0.67, 95% confidence interval 0.44 to 1.00). The mean adjusted quality-adjusted life-year difference between two arms was 0.043 (95% confidence interval −0.069 to 0.152) in favour of the combined oral contraceptive pill, although this cost an additional £533 (95% confidence interval 52 to 983) per woman. Limitations: Limitations include the absence of a no-treatment group and the fact that many women changed treatments over the 3 years of follow-up. Use of telephone follow-up to collect primary outcome data in those who failed to return questionnaires resulted in missing data for secondary outcomes. The COVID pandemic may have affected rates of further surgical treatment. Conclusions: At 36 months, women allocated to either intervention had comparable levels of pain, with both groups showing around a 40% improvement from presurgical levels. Although the combined oral contraceptive was cost-effective at a threshold of £20,000 per quality-adjusted life-year, the difference between the two was marginal and lower rates of repeat surgery might make long-acting reversible contraceptives preferable to some women. Future work: Future research needs to focus on evaluating newer hormonal preparations, a more holistic approach to symptom suppression and identification of biomarkers to diagnose endometriosis and its recurrence. Trial registration: This trial is registered as ISRCTN97865475. https://doi.org/10.1186/ISRCTN97865475. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 11/114/01) and is published in full in Health Technology Assessment; Vol. 28, No. 55. See the NIHR Funding and Awards website for further award information. The NIHR recognises that people have diverse gender identities, and in this report, the word ‘woman’ is used to describe patients or individuals whose sex assigned at birth was female, whether they identify as female, male or non-binary.


  • Open Access

    Barriers and facilitators to healthcare practitioners providing care for pregnant women with epilepsy: A systematic review and narrative synthesis

    by Anita Hughes, Annalise Weckesser, Elaine Denny, Fatima Junaid, Cathy Nelson-Piercy, Mairead Black, John Allotey, Shakila Thangaratinam, Judith Dyson


  • Open Access

    How to do qualitative research?

    by Elaine Denny, Annalise Weckesser